Pharma Aids Limited (DSE:PHARMAID)
499.20
+0.40 (0.08%)
At close: Jan 22, 2026
Pharma Aids Revenue
Pharma Aids had revenue of 119.14M BDT in the quarter ending September 30, 2025, with 14.84% growth. This brings the company's revenue in the last twelve months to 453.49M, up 5.19% year-over-year. In the fiscal year ending June 30, 2025, Pharma Aids had annual revenue of 438.09M with 4.00% growth.
Revenue (ttm)
453.49M
Revenue Growth
+5.19%
P/S Ratio
3.43
Revenue / Employee
4.82M
Employees
94
Market Cap
1.56B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 438.09M | 16.85M | 4.00% |
| Jun 30, 2024 | 421.23M | 112.74M | 36.54% |
| Jun 30, 2023 | 308.49M | -14.55M | -4.51% |
| Jun 30, 2022 | 323.05M | 42.76M | 15.25% |
| Jun 30, 2021 | 280.29M | 10.72M | 3.98% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Navana Pharmaceuticals | 9.52B |
| Techno Drugs | 3.23B |
| Orion Pharma | 3.23B |
| Asiatic Laboratories | 2.24B |
| Advent Pharma | 500.49M |
| Silco Pharmaceuticals | 428.63M |
| Silva Pharmaceuticals | 370.96M |
| Libra Infusions | 197.03M |